1. Home
  2. AMCI vs RANI Comparison

AMCI vs RANI Comparison

Compare AMCI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$7.14

Market Cap

150.0M

Sector

Finance

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

N/A

Current Price

$1.35

Market Cap

126.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCI
RANI
Founded
2021
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
126.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AMCI
RANI
Price
$7.14
$1.35
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
50.6K
740.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.05
EPS
N/A
N/A
Revenue
N/A
$1,028,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
$33.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$0.39
52 Week High
$15.75
$3.87

Technical Indicators

Market Signals
Indicator
AMCI
RANI
Relative Strength Index (RSI) 56.48 51.64
Support Level $5.84 $1.31
Resistance Level $7.75 $1.42
Average True Range (ATR) 0.66 0.08
MACD 0.06 0.01
Stochastic Oscillator 74.62 61.76

Price Performance

Historical Comparison
AMCI
RANI

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is an artificial intelligence services company that develops robotic solutions designed to support operational efficiency across sectors such as logistics and manufacturing. The company develops robotics and automation technologies designed to improve logistics operations. Its robots use sensors and visual AI to support real-time decision-making, contributing to safer and more efficient warehouse operations. It builds autonomous robots for use in logistics and warehousing.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: